ethyl tert-butyl 4-(3-(ethoxycarbonyl)phenyl)-5,6-dihydropyridine-1(2H)-carboxylate | 782493-24-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl tert-butyl 4-(3-(ethoxycarbonyl)phenyl)-5,6-dihydropyridine-1(2H)-carboxylate
• 英文别名: tert-butyl 4-(3-(ethoxycarbonyl)phenyl)-5,6-dihydropyridine-1(2H)-carboxylate；tert-butyl 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydropyridine-1(2H)-carboxylate；4-(3-ethoxycarbonyl-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester；tert-butyl 4-(3-ethoxycarbonylphenyl)-3,6-dihydro-2H-pyridine-1-carboxylate
• CAS: 782493-24-7
• 化学式: C₁₉H₂₅NO₄
• 分子量: 331.412
• InChiKey: IFGWJSXBQARZGF-UHFFFAOYSA-N

物化性质

• 沸点：
  448.3±45.0 °C(Predicted)
• 密度：
  1.125±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl tert-butyl 4-(3-(ethoxycarbonyl)phenyl)-5,6-dihydropyridine-1(2H)-carboxylate 在 palladium(II) hydroxide/carbon 氢气 作用下， 以 甲醇 为溶剂， 反应 18.0h， 生成 ethyl tert-butyl 4-(3-(ethoxycarbonyl)phenyl)piperidine-1-carboxylate
  参考文献：
  名称：

  Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors

  摘要：

  环戊基化合物通过酰胺基团与苯并噁唑基团相连，利用苯并噁唑环的环氮原子，并进一步用杂环基团取代，这些化合物由式I表示： 用于调节CCR-2趋化因子受体，以预防或治疗炎症和免疫调节性疾病和疾病，过敏性疾病，包括过敏性鼻炎，皮炎，结膜炎和哮喘，以及类风湿性关节炎和动脉粥样硬化等自身免疫病理病变；以及包含这些化合物的药物组合物和这些化合物和组合物的使用。

  公开号：

  US20070238723A1
• 作为产物：
  描述：

  N-叔丁氧羰基-4-哌啶酮 在 四(三苯基膦)钯 、 sodium carbonate 、 lithium chloride 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 乙二醇二甲醚 为溶剂， 反应 36.0h， 生成 ethyl tert-butyl 4-(3-(ethoxycarbonyl)phenyl)-5,6-dihydropyridine-1(2H)-carboxylate
  参考文献：
  名称：

  [EN] CHEMOKING RECEPTOR ANTAGONISTS
  [FR] ANTAGONISTES DES RÉCEPTEURS DE CHIMIOKINES

  摘要：

  本文揭示了化学受体拮抗剂的化学式(I)，其中G1、X1、X2和X3如规范中所定义。还描述了包含这种化合物的组合物；以及使用这种化合物和组合物治疗疾病和疾病的方法。

  公开号：

  WO2013010453A1

文献信息

• Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
  申请人：Goble D. Stephen

  公开号：US20070238723A1

  公开（公告）日：2007-10-11

  Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula I: which are used to modulate the CCR-2 chemokine receptor to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis; and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions.

  环戊基化合物通过酰胺基团与苯并噁唑基团相连，利用苯并噁唑环的环氮原子，并进一步用杂环基团取代，这些化合物由式I表示： 用于调节CCR-2趋化因子受体，以预防或治疗炎症和免疫调节性疾病和疾病，过敏性疾病，包括过敏性鼻炎，皮炎，结膜炎和哮喘，以及类风湿性关节炎和动脉粥样硬化等自身免疫病理病变；以及包含这些化合物的药物组合物和这些化合物和组合物的使用。
• [EN] CCR2 MODULATORS<br/>[FR] MODULATEURS DU CCR2
  申请人：CHEMOCENTRYX INC

  公开号：WO2016187393A1

  公开（公告）日：2016-11-24

  Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (I) and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of CCR2 receptors.

  提供了一些调节CCR2受体的化合物。这些化合物具有一般公式(I)，在制药组合物、治疗涉及CCR2受体病理性激活的疾病和疾病的方法中是有用的。
• Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
  申请人：Butora Gabor

  公开号：US20080081803A1

  公开（公告）日：2008-04-03

  The present invention is directed to compounds of the formula I: Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

  本发明涉及以下式I的化合物： 其中R1、R2、R3、R4、R5、R6、R7、R8、R9、X、n和虚线如本文所定义，这些化合物可用作趋化因子受体活性的调节剂。特别地，这些化合物可用作趋化因子受体CCR-2的调节剂。
• MICROBIOCIDAL HETEROCYCLES
  申请人：Sulzer-Mosse Sarah

  公开号：US20120142698A1

  公开（公告）日：2012-06-07

  The present invention relates to heterocyclic compounds of formula I which have microbiocidal activity, in particular fungicidal activity as well as methods of using the compounds of formula (I) to control microbes: wherein A is x-C(R 10 R 11 )—C(═O)—, x-C(R 12 R 13 )—C(═S)—, x-O—C(═O)—, x-O—C(═S)—, x-N(R 14 )—C(═O)—, x-N(R 15 )—C(═S)—, x-C(R 16 R 17 )—SO 2 — or X—N═C(R 30 )—, in each case x indicates the bond that is connected to R 1 ; T is CR 18 or N; Y 1 , Y 2 , Y 3 , and Y 4 are independently CR 19 or N; Q is O or S; n is 1 or 2; p is 1 or 2, providing that when n is 2, p is 1. R 1 is phenyl, pyridyl, imidazolyl, or pyrazolyl; wherein the phenyl, pyridyl, imidazolyl and pyrazolyl are each optionally substituted by 1 to 3 substituents independently selected from C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, halogen, cyano, hydroxy and amino; R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 10 , R 11 , R 12 , R 13 , R 16 , R 17 , R 18 , R 19 and R 30 each independently are hydrogen, halogen, cyano, C 1 -C 4 alkyl, or C 1 -C 4 haloalkyl; R 8 , R 14 and R 15 each independently are hydrogen or C 1 -C 4 alkyl; and R 9 is phenyl, benzyl or group (a): wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, halogen, cyano, hydroxy and amino; or a salt or a N-oxide thereof.

  本发明涉及公式I的杂环化合物，其具有微生物杀菌活性，特别是真菌杀菌活性，以及使用公式（I）化合物控制微生物的方法：其中A是x-C（R10R11）—C（═O）—，x-C（R12R13）—C（═S）—，x-O—C（═O）—，x-O—C（═S）—，x-N（R14）—C（═O）—，x-N（R15）—C（═S）—，x-C（R16R17）—SO2—或X—N═C（R30）—，在每种情况下，x表示与R1相连的键；T是CR18或N；Y1、Y2、Y3和Y4分别是CR19或N；Q是O或S；n为1或2；p为1或2，前提是当n为2时，p为1。R1是苯基、吡啶基、咪唑基或吡唑基；其中苯基、吡啶基、咪唑基和吡唑基各自可以选择性地被1至3个取代基取代，所述取代基独立选择自C1-C4烷基、C1-C4卤代烷基、卤素、氰基、羟基和氨基；R2、R3、R4、R5、R6、R7、R10、R11、R12、R13、R16、R17、R18、R19和R30各自独立地是氢、卤素、氰基、C1-C4烷基或C1-C4卤代烷基；R8、R14和R15各自独立地是氢或C1-C4烷基；而R9是苯基、苄基或(a)基团：其中苯基、苄基和(a)基团各自可以选择性地被1至3个取代基取代，所述取代基独立选择自C1-C4烷基、C1-C4卤代烷基、卤素、氰基、羟基和氨基；或其盐或N-氧化物。
• Microbiocidal heterocycles
  申请人：Sulzer-Mosse Sarah

  公开号：US08367844B2

  公开（公告）日：2013-02-05

  The present invention relates to heterocyclic compounds of formula I which have microbiocidal activity, in particular fungicidal activity as well as methods of using the compounds of formula (I) to control microbes: wherein A is x-C(R10R11)—C(═O)—, x-C(R12R13)—C(═S)—, x-O—C(═O)—, x-O—C(═S)—, x-N(R14)—C(═O)—, x-N(R15)—C(═S)—, x-C(R16R17)—SO2— or X—N═C(R30)—, in each case x indicates the bond that is connected to R1; T is CR18 or N; Y1, Y2, Y3, and Y4 are independently CR19 or N; Q is O or S; n is 1 or 2; p is 1 or 2, providing that when n is 2, p is 1. R1 is phenyl, pyridyl, imidazolyl, or pyrazolyl; wherein the phenyl, pyridyl, imidazolyl and pyrazolyl are each optionally substituted by 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyl, halogen, cyano, hydroxy and amino; R2, R3, R4, R5, R6, R7, R10, R11, R12, R13, R16, R17, R18, R19 and R30 each independently are hydrogen, halogen, cyano, C1-C4alkyl, or C1-C4haloalkyl; R8, R14 and R15 each independently are hydrogen or C1-C4alkyl; and R9 is phenyl, benzyl or group (a): wherein the phenyl, benzyl and group (a) are each optionally substituted with 1 to 3 substituents independently selected from C1-C4 alkyl, C1-C4 haloalkyl, halogen, cyano, hydroxy and amino; or a salt or a N-oxide thereof.

  本发明涉及式I的杂环化合物，其具有微生物杀菌活性，特别是具有真菌杀菌活性，以及使用式(I)化合物控制微生物的方法：其中A是x-C（R10R11）-C（═O）-，x-C（R12R13）-C（═S）-，x-O-C（═O）-，x-O-C（═S）-，x-N（R14）-C（═O）-，x-N（R15）-C（═S）-，x-C（R16R17）-SO2-或X-N═C（R30）-，在每种情况下，x表示连接到R1的键；T是CR18或N；Y1、Y2、Y3和Y4分别独立地是CR19或N；Q是O或S；n是1或2；p是1或2，前提是当n为2时，p是1。R1是苯基，吡啶基，咪唑基或吡唑基；其中苯基，吡啶基，咪唑基和吡唑基分别可以选择性地被1至3个取代基独立地选自C1-C4烷基，C1-C4卤代烷基，卤素，氰基，羟基和氨基；R2、R3、R4、R5、R6、R7、R10、R11、R12、R13、R16、R17、R18、R19和R30各自独立地是氢，卤素，氰基，C1-C4烷基或C1-C4卤代烷基；R8、R14和R15各自独立地是氢或C1-C4烷基；而R9是苯基，苄基或基团（a）：其中苯基，苄基和基团（a）各自可以选择性地被1至3个取代基独立地选自C1-C4烷基，C1-C4卤代烷基，卤素，氰基，羟基和氨基；或其盐或N-氧化物。